VIEWPOINTS PharmaShots Interview: Dermavant’s Philip M. Brown Shares Insights on the Clinical Data of Tapinarof Published in NEJMBySenior EditorFebruary 8, 20220Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Moshe Safran of RSIP Vision Share Insight on the 3D Reconstruction TechnologyBySenior EditorFebruary 7, 20220Comments
VIEWPOINTS PharmaShots Interview: Accenture Life Sciences’ Laura Dix Shares Insights on the New Rules of Engagement to Provide HCPs New InteractionsBySenior EditorFebruary 2, 20220Comments
VIEWPOINTS PharmaShots Interview: Nanobiotix’s Laurent Levy Shares Insights on the P-III (NANORAY-312) Study of NBTXR3 for the Treatment of Head and Neck Squamous Cell CarcinomaBySenior EditorJanuary 31, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in December 2021BySenior EditorJanuary 27, 20220Comments
SPOTLIGHT Spotlight Interview with Michael Sassano, CEO and Chairman of the Board for Somai PharmaceuticalsBySenior EditorJanuary 27, 20220Comments
VIEWPOINTS PharmaShots Interview: E&E CRO Consulting’s Ilse Eder Shares Insights on the Trends of Clinical Research & New Healthcare TechnologiesBySenior EditorJanuary 25, 20220Comments
THOUGHTSPOT The Ultimate Guide To COVID-19 Vaccines: Before, During, And After VaccinationBySenior EditorJanuary 24, 20220Comments
